Unjha Formulations Limited

As of June 30, 2026, Unjha Formulations Limited carries a market capitalization of 88.98M, placing it among publicly traded companies globally. Its enterprise value stands at 88.98M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Unjha Formulations Limited has 4.48M shares outstanding.

As of June 30, 2026, Unjha Formulations Limited trades at a trailing price-to-earnings ratio of 18.89.

As of June 30, 2026, Unjha Formulations Limited trades at an EV/EBITDA multiple of 10.90 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.58 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 13.37 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 88.98M versus a market cap of 88.98M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Unjha Formulations Limited recorded 2.49M in income tax expense. That works out to an effective tax rate of 34.56, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 7.21M, leaving 4.72M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Unjha Formulations Limited's stock has gained approximately 17.14% over the past 52 weeks. The 50-day moving average sits at 30.18, while the 200-day moving average is 23.82.

Over the twelve months ended June 30, 2026, Unjha Formulations Limited generated 152.79M in revenue and converted that into 4.72M in net income, yielding earnings per share of 1.05. EBITDA reached 8.16M, while operating income came in at 6.66M.

Over the twelve months ended June 30, 2026, Unjha Formulations Limited posted a gross margin of 21.62, reflecting its pricing power and cost economics. The operating margin of 4.36 and net profit margin of 3.09 provide insight into operational efficiency.